Lv5
1090 积分 2022-09-21 加入
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
27天前
已完结
Restoring order at the cell cycle border: Co-targeting CDK4/6 and CDK2
27天前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
27天前
已完结
Targeting CDK2 to circumvent treatment resistance in HR+ breast cancer
2个月前
已完结
TarIKGC: A Target Identification Tool Using Semantics-Enhanced Knowledge Graph Completion with Application to CDK2 Inhibitor Discovery
2个月前
已完结
Design of small molecules for CDK-2 inhibition in colorectal cancer based on substructure search
2个月前
已完结
Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease
3个月前
已完结
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective
3个月前
已完结
Meeting report: DMPK optimisation strategies and quantitative translational PKPD frameworks to predict human PK and efficacious dose of Targeted protein degraders
3个月前
已完结
Property-based optimisation of PROTACs
3个月前
已完结
皖公网安备34019202002308
